{"abdominal distension": 2.7, "amyloidosis": 153.93, "ascites": 2.23, "atrial fibrillation": 8.42, "atrial flutter": 15.6, "atrioventricular block complete": 11.65, "balance disorder": 2.34, "bradycardia": 2.95, "brain natriuretic peptide increased": 30.16, "cardiac amyloidosis": 736.74, "cardiac disorder": 4.74, "cardiac failure": 26.39, "cardiac failure chronic": 315.91, "cardiac failure congestive": 3.32, "cardiomyopathy": 11.52, "carpal tunnel syndrome": 11.56, "cerebral infarction": 2.22, "cognitive disorder": 2.18, "condition aggravated": 4.92, "constipation": 2.07, "death": 2.67, "dementia": 5.74, "diastolic dysfunction": 38.13, "disease progression": 9.38, "disease recurrence": 2.31, "dysphagia": 4.75, "dyspnoea exertional": 5.13, "ejection fraction decreased": 9.19, "fall": 3.57, "flatulence": 4.27, "fluid retention": 5.78, "gait disturbance": 2.08, "gait inability": 2.47, "gamma-glutamyltransferase increased": 3.53, "gastrointestinal disorder": 2.17, "general physical health deterioration": 2.86, "glomerular filtration rate decreased": 6.11, "gout": 7.14, "hereditary neuropathic amyloidosis": 4041.79, "hypervolaemia": 8.24, "hypoacusis": 2.39, "intentional product misuse": 3.06, "left ventricular dysfunction": 13.02, "left ventricular hypertrophy": 81.15, "loss of personal independence in daily activities": 2.8, "mitral valve incompetence": 17.3, "n-terminal prohormone brain natriuretic peptide increased": 56.79, "neuropathy peripheral": 2.84, "oedema": 2.93, "oedema peripheral": 3.29, "off label use": 3.54, "orthostatic hypotension": 7.12, "pericardial effusion": 3.21, "pleural effusion": 3.38, "polyneuropathy": 10.92, "product use in unapproved indication": 6.88, "pulmonary oedema": 2.41, "therapeutic response unexpected": 8.29, "tricuspid valve incompetence": 26.95, "urinary tract infection": 2.06, "ventricular hypokinesia": 29.93, "weight decreased": 3.57}